Table 9. Comparison of the EQ-5D utility value and QOL-ACD total score according to the presence or absence of anorexia in patients stratified by stage, purpose of chemotherapy and age.
| n | EQ-5D | QOL-ACD | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Grade 0 | Grade 1–3 | Grade 0 | Grade 1–3 | p | Grade 0 | Grade 1–3 | p | ||
| Stage | |||||||||
| 1 | 6 | 9 | -0.07±0.12 | -0.24±0.18 | 0.061 | 1.33±5.68 | -14.33±10.00 | 0.004* | |
| 2–4 | 21 | 11 | -0.05±0.17 | -0.14±0.12 | 0.159 | 1.00±11.34 | -7.91±5.49 | 0.006* | |
| Purpose of chemotherapy | |||||||||
| Neoadjuvant | 12 | 5 | -0.10±0.20 | -0.07±0.09 | 0.718 | -0.58±14.06 | -9.20±9.28 | 0.231 | |
| Not neoadjuvant | 15 | 15 | -0.02±0.11 | -0.22±0.15 | <0.001 * | 2.40±5.97 | -11.33±8.21 | <0.001* | |
| Age (year) | |||||||||
| <49 | 4 | 7 | -0.11±0.13 | -0.18±0.11 | 0.410 | 4.75±5.19 | -11.29±4.61 | <0.001* | |
| ≥50 | 23 | 13 | -0.05±0.17 | -0.19±0.18 | 0.021 * | 0.43±10.85 | -10.54±9.90 | 0.005* | |
*p<0.05